It was recently recognized that some chronic myeloid leukemia patients with a complete molecular response could sustain that response after discontinuation of imatinib. To characterize the clinical outcomes and profiles of chronic phase chronic myeloid leukemia patients who could discontinue imatini...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!